Oncolytics Biotech
ONCY
#9622
Rank
C$0.14 B
Marketcap
C$1.19
Share price
2.50%
Change (1 day)
-26.45%
Change (1 year)

Oncolytics Biotech (ONCY) - Cash on Hand

Cash on Hand as of March 2026 : C$7.73 Million

According to Oncolytics Biotech 's latest financial reports the company has C$7.73 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oncolytics Biotech - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31C$7.12 M-55.19%
2024-12-31C$15.89 M-54.45%
2023-12-31C$34.9 M8.63%
2022-12-31C$32.13 M-22.09%
2021-12-31C$41.24 M32.12%
2020-12-31C$31.21 M120.68%
2019-12-31C$14.14 M3.24%
2018-12-31C$13.7 M15.78%
2017-12-31C$11.83 M-16.19%
2016-12-31C$14.12 M-45.83%
2015-12-31C$26.06 M61.12%
2014-12-31C$16.17 M-40.55%
2013-12-31C$27.21 M27.87%
2012-12-31C$21.28 M-38.71%
2011-12-31C$34.72 M-19.02%
2010-12-31C$42.88 M25.04%
2009-12-31C$34.29 M158.55%
2008-12-31C$13.26 M-47.78%
2007-12-31C$25.39 M-7.92%
2006-12-31C$27.58 M-31.9%
2005-12-31C$40.5 M19.52%
2004-12-31C$33.88 M63.25%
2003-12-31C$20.75 M148.73%
2002-12-31C$8.34 M-44.29%
2001-12-31C$14.98 M-14.9%
2000-12-31C$17.6 M288.59%
1999-12-31C$4.53 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eli Lilly
LLY
C$7.43 B 96,058.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$14.75 B 190,797.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
C$1.37 B 17,675.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
C$39.12 M 406.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$5.26 B 68,004.86%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
C$0.10 B 1,309.03%๐Ÿ‡บ๐Ÿ‡ธ USA